The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...
C3G and IC-MPGN can be difficult to diagnose because they are so rare and their symptoms are vague and nonspecific. A kidney biopsy is considered the gold standard and usually needed to confirm the ...
First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD CTx001 is an investigational AAV-based gene therapy designed to deliver ...
Objective SLE is a systemic autoimmune disease in which the complement system plays a key pathogenic role, yet the ...
Lake Erie College of Osteopathic Medicine (LECOM) is reinforcing its commitment to accessible and affordable pharmacy ...
Jarrod Bowen Emerges as Summer TargetLiverpool’s summer rebuild is already taking shape, and fresh reporting from DaveOCKOP ...
Transaction expected to approximately triple NEXGEL’s annual revenue to approximately $35 million and is expected to be immediately accretive to ...
It’s finally draft week and I’ll be wrapping up my pre-draft coverage with several big boards based around research on George ...
Dr. Cinik, opens new tab has officially launched a dedicated hair restoration clinic on London's prestigious Harley Street, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results